RET Inhibitors in RET Fusion-Positive Lung Cancers: Past, Present, and Future. [PDF]
Chen MF, Repetto M, Wilhelm C, Drilon A.
europepmc +1 more source
Screening for brain metastases in patients with advanced non-small cell lung cancer and an actionable genomic alteration: A structured literature review. [PDF]
Huijs JWJ +7 more
europepmc +1 more source
Bach\u27s Oratorios: The Parallel German-English Texts, With Annotations [PDF]
Bach, J. S., Marissen, Michael
core +1 more source
Systemic therapies for medullary thyroid carcinoma: state of the art. [PDF]
Román-González A +4 more
europepmc +1 more source
Primary Resistance to RET Inhibition in a RET Fusion-Positive Pancreatic Neuroendocrine Carcinoma. [PDF]
McKinley BJ, Coston TW, Starr JS.
europepmc +1 more source
Clinical Activity of Selpercatinib in RET-mutant Pheochromocytoma.
Deschler-Baier B +7 more
europepmc +1 more source
CNS Protective Effect of Selpercatinib in First-Line RET Fusion-Positive Advanced Non-Small Cell Lung Cancer. [PDF]
Pérol M +13 more
europepmc +1 more source
Treatment Outcomes and Toxicities of Multiple Tyrosin Kinase Inhibitors for Metastatic Medullary Thyroid Cancer: A Case Series. [PDF]
Mormando M +5 more
europepmc +1 more source
Oncogenic Fusions in NSCLC: From Mechanisms to Clinical Applications. [PDF]
Theik NWY +7 more
europepmc +1 more source

